| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Institute of Molecular Animal Breeding and Biotechnology, Ludwig-Maximilians-University, Munich, Germany
Institute of Experimental Genetics, GSF Research Center for Environment and Health, Neuherberg, Germany
1 To whom correspondence should be addressed. e-mail: b.aigner{at}gen.vetmed.uni-muenchen.de
Hypercholesterolemia is caused by multiple environmental factors and genetic predispositions, and plays an important role in the development and pathogenesis of various human diseases. In this study, we aimed to establish randomly mutant mouse lines showing hypercholesterolemia for their further use in the detection of novel causative alleles. In the Munich ENU Mouse Mutagenesis Project, clinical chemistry blood analysis was performed on more than 15,000 G1 mice and 230 G3 pedigrees of chemically mutagenized mice to detect dominant and recessive mutations leading to an increased plasma total cholesterol level. Using inbred C3HeB/FeJ mice we identified more than 100 animals consistently showing hypercholesterolemia. Transmission of the altered phenotype to the subsequent generations led to the production of nine hypercholesterolemic lines. A single line showed further obvious deviations in the analysis of additional clinical chemistry blood parameters.
Thus, the lines produced will contribute to the search for alleles that selectively cause primary hypercholesterolemia.
Abbreviations: C3H, C3HeB/FeJ [inbred mouse strain]; ENU, N-ethyl-N-nitrosourea; Gn, generation number; HDL-C, HDL cholesterol; LDL-C, LDL cholesterol
Supplementary key words cholesterol • ethylnitrosourea • high density lipoproteins • low density lipoproteins • phenotype-driven screen
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Aigner, B. Rathkolb, N. Herbach, M. H. de Angelis, R. Wanke, and E. Wolf Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E232 - E240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Herbach, B. Rathkolb, E. Kemter, L. Pichl, M. Klaften, M. H. de Angelis, P. A. Halban, E. Wolf, B. Aigner, and R. Wanke Dominant-Negative Effects of a Novel Mutated Ins2 Allele Causes Early-Onset Diabetes and Severe {beta}-Cell Loss in Munich Ins2C95S Mutant Mice Diabetes, May 1, 2007; 56(5): 1268 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Aigner, B. Rathkolb, N. Herbach, E. Kemter, C. Schessl, M. Klaften, M. Klempt, M. H. de Angelis, R. Wanke, and E. Wolf Screening for increased plasma urea levels in a large-scale ENU mouse mutagenesis project reveals kidney disease models Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1560 - F1567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Reue and L. Vergnes Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Approaches to lipid metabolism gene identification and characterization in the postgenomic era J. Lipid Res., September 1, 2006; 47(9): 1891 - 1907. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
